King Street Leases Additional 107,000 SF at Lexington Campus to Dicerna PharmaceuticalsNovember 07, 2022
LEXINGTON — King Street Properties, owners/developers/operators of life sciences properties in Massachusetts, has added a major expansion at its Hayden Avenue campus in Lexington. Dicerna Pharmaceuticals Inc. currently occupies more than 90,000 square feet at 75 Hayden Avenue and will add an additional 107,283 square feet in the nearby 65 Hayden Avenue building, according to a release.
“We are thrilled to continue our long relationship as they expand their presence in Lexington,” says Chris Rouches, managing director at King Street. “Life sciences continue to thrive throughout the greater Boston area and the King Street team is proud to provide first-rate facilities to support companies conducting innovative work.”
King Street has been delivering quality space for life science companies for over 20 years and has a relationship with the tenant dating back to 2014 when the company entered into its first lease with King Street for 37,000 square feet. With this lease expansion, the company will occupy more than 275,000 square feet in Lexington – nearly 200,000 of that with King Street Properties.
The Hayden Research Campus, which is jointly owned by King Street Properties and Healthpeak Properties, is located adjacent to Routes 2 and 95 in Lexington, Mass. The site houses several life sciences firms including Dicerna, Frequency Therapeutics, Concert Pharmaceuticals, Valo Health, Voyager Therapeutics, and Takeda Pharmaceuticals.